Assembly Biosciences (ASMB): Rasio rega marang prakiraan pendapatan

Geopolitical tensions and sanctions are hindering global hepatitis research, a trend reflected in the indicator's price action on the GURU.Markets chart; meanwhile, the value of 5.40 corresponds to the current forward P/S metric of the business. Assembly Biosciences (ASMB) is scaling its virology portfolio through external partner capital, leveraging a deep scientific foundation and the development of core protein inhibitors to combat liver diseases.

ASMB assemblybio.com: Rasio kapitalisasi marang dodolan sing dikarepake ing interval 04.07.2022 - 13.11.2026

Ringkesan rincian data analitis Assembly Corp (ASMB)

- rega saiki lan proyeksi nilai saham:

Rega saham Assembly Biosciences, Inc.|ASMB - Prakiraan konsensus analis

- data kapitalisasi bursa:

Nilai pasar Assembly Corp|ASMB - Rega Tumbas Perusahaan

- indikator nilai buku ekuitas:

Aset Bersih saben Siji Saham Assembly Biosciences|ASMB - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku assemblybio.com|ASMB - Aset Perusahaan

- data liabilitas lan likuiditas perusahaan:

Utang marang Ekuitas Assembly Biosciences|ASMB - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Assembly Biosciences|ASMB - Utang perusahaan|Rasio utang marang kapitalisasi buku Assembly Corp|ASMB - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Assembly Biosciences|Indikator likuiditas cepet assemblybio.com

- data bathi bisnis lan rasio investasi:

ASMB - Bathi pungkasan|Proyeksi bathi mangsa ngarep Assembly Biosciences|ASMB - Rasio rega marang bathi|Pangali Forward P/E Assembly Biosciences Inc|ASMB - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Assembly Corp|ASMB - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Assembly Biosciences|ASMB - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan assemblybio.com|ASMB - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Assembly Biosciences

- indikator volume dodolan lan pendapatan:

ASMB - Pendapatan reged perusahaan|Prakiraan volume dodolan Assembly Biosciences, Inc.|ASMB - Rega marang dodolan|Rasio rega marang prakiraan pendapatan Assembly Corp

Ringkesan analitik perusahaan:ASMB (Assembly Biosciences, Inc.)

For the biotechnological profile of Assembly Biosciences (ASMB), the forward P/S trend serves as an indicator of market expectations regarding future cash flows. This metric compares current market capitalization with projected revenue, demonstrating a risk premium given the business's dependence on US and EU regulatory verdicts, where the absence of a commercial market leaves the valuation hostage to clinical trial results.

Karo sapa Assembly Biosciences saingan

Multiplikator Forward P/S ARWR (Arrowhead Pharmaceuticals, Inc.)|Multiplikator Forward P/S Mirum Pharmaceuticals, Inc. MIRM|DVAX - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Tekmira Pharmaceuticals ABUS|Inventiva S.A. (IVA) - Rasio rega marang prakiraan pendapatan|GYRE - Rasio kapitalisasi marang dodolan sing dikarepake|GALT (Galectin Therapeutics, Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Genfit Corp GNFT|Rasio rega marang prakiraan pendapatan DURECT Corporation (DRRX)|Multiplikator forward rega marang pendapatan aligos.com ALGS|Multiplikator Forward P/S BIVI (BioVie)|Galmed Pharmaceuticals Ltd - Rasio rega marang prakiraan pendapatan|NDRA - Rasio rega marang prakiraan pendapatan|HEPA: Rasio rega marang prakiraan pendapatan